AZD3427 effects on renal perfusion in heart failure patients with reduced ejection fraction and renal impairment

Trial Identifier:	D8330C00004
Sponsor:	AstraZeneca
Collaborator:	Clinical Trial Consultants (CTC) Karolinska Institutet
Start Date:	October 2024
Primary Completion Date:	September 2025
Study Completion Date:	September 2025
Condition:	Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
SE	Solna, SE, 171 64

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.